Delivery Order SPE2DB24D8002-SPE2DB25FJNFH
Award Date
2/26/25
Potential Completion Date
2/27/25
Potential Value
$4.8K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $5,346.71 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of fluticasone-salmeterol 230-21 12GM pharmaceutical products to support U.S. Armed Forces medical operations. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, which allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,828.37 firm fixed-price contract is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product, to support U.S. Armed Forces medical operations. The contract is not set aside and is part of Dakota Drug, Inc.'s $999,999,999.00 Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's ECAT Generation V...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $1,128.03 contract is for the delivery of Fluticasone-Salmeterol 500-50 60s, a pharmaceutical product used to treat respiratory conditions. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with DLA Troop Support Medical's ECAT...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,285.48 firm fixed-price contract is for the delivery of 4563652204 FLUTICASONE-SALMETEROL 230-21 12GM, a pharmaceutical product. The award is under the DLA Troop Support Medical's ECAT Generation V Program, a $999,999,999.00 Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. This contract allows the company to provide a wide range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,553.05, is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a respiratory medication, to support U.S. Armed Forces medical operations. The contract is a firm fixed-price, non-set-aside award with a completion date of January 28, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business that specializes in providing pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government. The contract, valued at $7,225.70, is a firm fixed-price delivery order for the supply of Fluticasone-Salmeterol 115-21 12GM inhalers. The award is associated with a larger Indefinite Delivery Contract (IDC) between Dakota...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA). The $6,172.15 firm fixed-price delivery order contract is for the supply of Fluticasone-Salmeterol 230-21 12GM, a respiratory medication, to the DLA. This award is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide a wide...
This federal contract award, valued at $4,206.61, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of 4566601984 units of the pharmaceutical product Fluticasone-Salmeterol 115-21 12GM, a respiratory medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract has a firm fixed-price delivery order structure and an ultimate completion date of December 4, 2024....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract has a firm fixed price of $3,085.17 and a period of performance through January 31, 2024. The contract is not set-aside and is part of the DLA Troop Support Medical's ECAT Generation V Program, a large Indefinite Delivery Contract (IDC) with a ceiling value...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of fluticasone propionate HFA 220 mcg 12 gm inhalers to support DLA Troop Support Medical's medical supply operations for the U.S. Armed Forces. The contract has a ceiling value of $1,254.40 and an ultimate completion date of August 23, 2024. Dakota Drug, Inc. also holds a single-award Indefinite...